JENNIFER BEARD: Open Payments
NPI 1679336002 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $182 |
| Axsome Therapeutics, Inc. | 5 | $180 |
| ABBVIE INC. | 6 | $103 |
| E.R. Squibb & Sons, L.L.C. | 1 | $51 |
| Corium, LLC | 3 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Alkermes, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: AUSTEDO XR, Auvelity, VRAYLAR, COBENFY, Azstarys, SPRAVATO, REXULTI, CAPLYTA.
Industry payments across KS — which companies pay providers there.
